Wall Street Bullish on AtaiBeckley (ATAI), Here's Why
AtaiBeckley Inc. (NASDAQ:ATAI) is one of the Best Penny Stocks That Will Skyrocket. Wall Street is bullish on AtaiBeckley Inc. (NASDAQ:ATAI) with analysts’ 12-month median price target reflecting more than 202% upside. Recently, on January 28, Patrick Trucchio from H.C. Wainwright reiterated a Buy rating on the stock with a $15 price target. Earlier, Eddie Hickman from Guggenheim also initiated AtaiBeckley Inc. (NASDAQ:ATAI) with a Buy rating and a $11 price target.
Hickman from Guggenheim noted that the company is a differentiated leader in next-generation psychiatry. The analyst also highlighted the recent merger with Beckley Psytech, which gives the company full ownership of BPL-003. BPL-003 is a lead asset that treats treatment-resistant depression and has shown compelling results in Phase IIIb efficacy and durability. The analyst believes that BPL-003 is strongly positioned for rapid clinical adoption and commercial scaling.
Phase 2 trials of BPL-003 showed sustained MADRS score reductions, with 63% responder rates and 48% remission rates after a second dose. Moreover, Phase 3 trials are planned for Q2 2026 following FDA Breakthrough Therapy Designation.
AtaiBeckley Inc. (NASDAQ:ATAI) is a clinical-stage biopharmaceutical company that researches, develops, and commercializes mental health treatments in the US, Germany, and Canada.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Nonfarm Payrolls Significantly Below Expectations! U.S. Added 29,000 Jobs in August vs. Expected 90,000; U.S. Treasury Yields Fall, U.S. Stock Futures Rise
In September, non-farm employment in the United States increased by only 29,000, far below the expected 90,000, and the unemployment rate rose slightly from 4.1% in August to 4.2%. After the data release, the probability of a Federal Reserve rate hike in October dropped from 22% to 17%, and the expected cumulative rate hike for the remaining two meetings of the year decreased to about 21 basis points. The yield on two-year U.S. Treasury bonds dropped 10 basis points in a single day, while S&P 500 futures rose by 0.8%. Economists attribute the unusual weakness to distortions from seasonal adjustment factors rather than a substantive shift in the labor market.
JPMorgan crypto symposium signals bigger ETF push for digital assets
Vylor stock slides 1.1% to $67.03, testing support in session two
Crypto prices
More
